Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. by Wittwer, F et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.unizh.ch
Year: 2001
Lilliputian: an AF4/FMR2-related protein that controls cell
identity and cell growth
Wittwer, F; van der Straten, A; Keleman, K; Dickson, B J; Hafen, E
Wittwer, F; van der Straten, A; Keleman, K; Dickson, B J; Hafen, E. Lilliputian: an AF4/FMR2-related protein that
controls cell identity and cell growth. Development 2001, 128(5):791-800.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
Development 2001, 128(5):791-800
Wittwer, F; van der Straten, A; Keleman, K; Dickson, B J; Hafen, E. Lilliputian: an AF4/FMR2-related protein that
controls cell identity and cell growth. Development 2001, 128(5):791-800.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
Development 2001, 128(5):791-800
Lilliputian: an AF4/FMR2-related protein that controls cell
identity and cell growth
Abstract
Members of the AF4/FMR2 family of nuclear proteins are involved in human diseases such as acute
lymphoblastic leukemia and mental retardation. Here we report the identification and characterization of
the Drosophila lilliputian (lilli) gene, which encodes a nuclear protein related to mammalian AF4 and
FMR2. Mutations in lilli suppress excessive neuronal differentiation in response to a constitutively
active form of Raf in the eye. In the wild type, Lilli has a partially redundant function in the Ras/MAPK
pathway in differentiation but it is essential for normal growth. Loss of Lilli function causes an
autonomous reduction in cell size and partially suppresses the increased growth associated with loss of
PTEN function. These results suggest that Lilli acts in parallel with the Ras/MAPK and the PI3K/PKB
pathways in the control of cell identity and cellular growth.
INTRODUCTION 
In the development of multicellular organisms, growth and
differentiation are tightly coordinated. Although significant
progress has been made in the understanding of these two
processes individually, we know relatively little about how
differentiation is integrated with cellular growth. The first step
towards differentiation, the specification of cell fate or tissue
types, frequently depends on cellular interactions mediated by
conserved signaling pathways. One of the best understood
intracellular signaling pathways involves the activation of the
small G-protein Ras in response to the stimulation of growth
factor receptors including the receptor tyrosine kinase (RTK)
family (for review see Boguski and McCormick, 1993;
Rommel and Hafen, 1998; Frame and Balmain, 2000).
Activation of Ras triggers a highly conserved cascade of
kinases including Raf, MEK and MAP kinase (MAPK). In the
Drosophila eye, Ras signaling is required for cell growth,
survival of postmitotic cells (Bergmann et al., 1998;
Dominguez et al., 1998, Kurada and White, 1998), and the
specification of ommatidial cell fates (reviewed by Freeman,
1997). Studies in the Drosophila wing have shown that loss of
Ras function reduces cell size (Diaz-Benjumea and Hafen,
1994). In the absence of Ras, cell cycle length is prolonged and
cells accumulate at the G1/S transition (Prober and Edgar,
2000). 
The role of Ras in growth control is shared with the PI3-
Kinase/Protein Kinase B (PI3K/PKB) pathway (Oldham
et al., 2000a; Weinkove and Leevers, 2000). Cells lacking
components of the PI3K/PKB pathway grow more slowly and
divide at a smaller size. Neither partial nor complete loss-of-
function mutations in genes encoding components of this
pathway affect the differentiation or patterning of adult
structures. In mammalian cells, the Ras/MAPK and
PI3K/PKB pathways cooperate in the control of cell cycle
progression. Transition from G1 into S phase of the cell cycle
requires the activation of both pathways (Gille and
Downward, 1999; Jones et al., 1999). Little is known,
however, about where and how these two pathways converge
to regulate growth. In this paper, we present evidence that the
product of the lilliputian (lilli) gene cooperates with both the
Ras/MAPK and the PI3K/PKB pathway in Drosophila in the
control of cell fate and cell size. 
Mutations in lilli were identified in a screen for dominant
suppressors of the rough eye phenotype caused by constitutive
activation of Raf during eye development (Dickson et al.,
1996). Here we show that Lilli plays a partially redundant
function downstream of Raf in cell fate specification in the
developing eye. In addition, complete loss of Lilli function
leads to a reduction in cell and organ size. The lilli gene
encodes a nuclear protein related to the AF4/FMR2 family. In
humans, mutations affecting genes of this family are associated
with specific diseases. Loss of FMR2 gene transcription causes
mental retardation (Chakrabarti et al., 1996; Gecz et al., 1996;
Gu et al., 1996). Translocations between MLL (a human
trithorax-related gene) and AF4 or AF5q31 are involved in
acute lymphoblastic leukemia (Domer et al., 1993; Nakamura
et al., 1993; Taki et al., 1999, and references therein). Our
results provide the first insight into the function of this class of
transcription factors during Drosophila development.
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Members of the AF4/FMR2 family of nuclear proteins are
involved in human diseases such as acute lymphoblastic
leukemia and mental retardation. Here we report the
identification and characterization of the Drosophila
lilliputian (lilli) gene, which encodes a nuclear protein
related to mammalian AF4 and FMR2. Mutations in lilli
suppress excessive neuronal differentiation in response to a
constitutively active form of Raf in the eye. In the wild type,
Lilli has a partially redundant function in the Ras/MAPK
pathway in differentiation but it is essential for normal
growth. Loss of Lilli function causes an autonomous
reduction in cell size and partially suppresses the increased
growth associated with loss of PTEN function. These results
suggest that Lilli acts in parallel with the Ras/MAPK and
the PI3K/PKB pathways in the control of cell identity and
cellular growth.
Key words: AF4/FMR2, Cell size, Differentiation, Drosophila
melanogaster, PTEN, lilliputian (lilli) 
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MATERIALS AND METHODS
Genetics
13 EMS-induced alleles and three P-element alleles (lilliP1=k05431,
lilliP2=k07920, lilliP4=k16124; Torok et al., 1993) of the
Su(Raf)2A/lilli complementation group were isolated (Dickson et al.,
1996). lilli was mapped to the cytological interval 23C1-2 by
recombination mapping (Dickson et al., 1996) and by non-
complementation with the deficiencies Df(2L)C144 and Df(2L)JS17.
The chico1 allele and the PTEN117.35 allele have been described
previously (Boehni et al., 1999; Oldham et al., 2000b). The ey-FLP
system has been described by Newsome (Newsome et al., 2000).
Clonal analysis
Different lilli alleles were recombined onto FRT40 chromosomes and
clonal analysis was performed using the FLP/FRT system described
by Xu and Rubin (1993). For the generation of clones in the adult eye,
larvae of the genotype y w hs-Flp; lilli FRT40/ P(w+) FRT40 were
subjected to a heat shock 24-48 hours after egg deposition (AED) for
1 hour at 37°C to induce mitotic recombination. Histological sections
of the eyes were done as described previously (Basler and Hafen,
1988). To generate clones in the imaginal discs, larvae of the genotype
y w hs-Flp/y w; lilli FRT40/P(arm-lacZ w+) FRT40 were subjected to
a heat shock 48-72 hours AED for 25 minutes at 33°C to induce
mitotic recombination at a low frequency. Larvae at late third instar
stage were dissected. Discs were fixed and permeabilized and stained
with antibodies. Antibodies were: mouse anti- b -gal (1/2000,
Promega), rabbit anti-phosphohistone H3 (1:2000, Upstate
biotechnology) and FITC-secondary antibodies (1/200, Jackson
ImmunoResearch). Nuclei were stained using the TO-PRO3 DNA
stain (T3605, Molecular Probes). Pictures were taken on a Leica TCS-
NT confocal laser scanning microscope and clone size was measured
by using the NIH image program. The TUNEL assay was performed
as described by Boehni (Boehni et al., 1999).
Cloning of lilli
Genomic DNA fragments flanking each of the three P-element
insertions were cloned by plasmid rescue (Mlodzik et al., 1990) and
sequenced. This allowed us to locate the lilli gene on contig
AC007765 of the Berkeley Drosophila Genome Project (BDGP)
which is consistent with the previous cytological localization of lilli
to the interval 23C1-2. Overlapping partial lilli cDNAs were used to
reconstruct the full length cDNA sequence. This sequence data has
been submitted to the GenBank database under accession number
AF293971. cDNA clones were isolated from a l gt10 third instar eye-
antennal disc library and by searching the BDGP database. The
longest cDNAs identified were LD15159, GH23691 and LD18077.
LD15159 contains the sequence of exons 1, 2 and the first part of exon
3, while GH23691 and LD18077 contain the cDNA sequence of the
3¢ part of lilli starting within exon 7. LD18077 had a much longer 3¢
UTR than GH23691. A polyadenylation signal was identified only in
the 3¢ UTR of LD18077, but not of GH23691, suggesting that the
latter cDNA corresponds to a truncated message.
The Genescan program (Burge and Karlin, 1997) predicted the 3 ¢
end of exon 3 and the 5¢ end of exon 7 and in addition exons 4-6 that
were not present in the isolated cDNAs. The missing part of the lilli
cDNA sequence was isolated by reverse transcriptase-PCR (RT-PCR).
RNA from Drosophila embryos and larvae was isolated and used to
synthesize first strand cDNA with random or oligo-dT primers. PCR
was performed by using different combinations of primers, that
matched the sequences of cDNAs LD15159 and GH23691 or of the
predicted exons 4-6. We were able to amplify and sequence partial
overlapping cDNAs spanning exons 2 and 3 (with primers LD5
5¢ -TACATATACAACATCGGCCG-3 ¢ and FW6 5¢ -GTAGTTGATC-
TAGTTGTTGCTG-3¢ ), exon 3 to exon 5 (with primers oFW22
5¢ -CCTCGACCTTAACCCTTTGG-3 ¢ and oFW24 5¢ -GTGACTCC-
GGAAGCTGCTTTG-3¢ ), and exon 5 to exon 7 (with primers oFW23
5¢ -AGGCAAGCCAAATGCCTCTG 3 ¢ and oFW26 5¢ -CCGCTCA-
CGTTCTCGTTCC-3 ¢ ). 
In situ hybridization to whole-mount embryos was performed as
described by Tautz and Pfeifle (1989). Antisense RNA probes were
generated with the DIG RNA labeling kit (Boehringer Mannheim)
using cDNA LD18077 as a template. Sense probes generated in
parallel with the same template were used as negative controls.
Molecular characterization of lilli alleles
Genomic DNA from flies heterozygous for lilli was isolated. DNA
fragments corresponding to exons 3-12 were amplified by PCR and
either sequenced directly or subcloned, using the pCRII-Topo cloning
kit (Invitrogen), before sequencing. PCR-induced mutations were
excluded by sequencing several independent PCR products for each
allele.
Generation of flies expressing lilli transgenes
To generate the UAS-lilli rescue construct a 4.4 kb genomic fragment
containing the coding part of exon 3 and ending at the NheI site within
exon 7, was fused upstream of the lilli cDNA GH23691 (GH23691
fragment starting with NheI site in exon 7 and ending with exon 12;
Fig. 4A). This fusion gene was subcloned into the pUAST Drosophila
transformation vector (Brand and Perrimon, 1993) to generate UAS-
lilli (construct pFW13). The HA-tag was introduced at the 3 ¢ end of
the open reading frame in UAS-lilli using pMZ55 (a gift from M.
Zecca and D. Nellen) to generate UAS-lilli-HA (construct pFW9). The
UAS-lilli construct was expressed by using the UAS-GAL4 system
(Brand and Perrimon, 1993). The driver lines were hs-GAL4 (obtained
from the Bloomington stock center) and sE-sP-GAL4, which
expresses GAL4 under control of the sev-enhancer-sev-promoter
regulatory elements in R7 precursor cells (P. Maier and E. H.,
unpublished results). 
Subcellular localization of Lilli-HA was analyzed in third instar
larvae of the genotype y w; UAS-lilli-HA/+, hs-GAL4/+. Salivary
glands were dissected 90 minutes after heat shocking for 1 hour at
37°C. They were fixed, permeabilized and stained with the mouse
anti-HA antibodies (1/1500, Boehringer Mannheim) and FITC
secondary antibodies (1/60). Pictures were taken using a Leica TCS-
NT confocal laser scanning microscope. For generating marked clones
overexpressing the UAS-lilli rescue construct transgenic flies were
used containing the GMR regulatory sequence (Hay et al., 1997) and
the GAL4 gene separated by a flip-out cassette containing the w+
minigene as a marker (F. Rintelen and E. H., unpublished results). In
heat shocked larvae of the genotype y w hs-Flp/y w; GMR>FRT
white+ FRT>GAL4/UAS-lilli the w+ cassette is removed in clones thus
permitting expression of UAS-lilli under the control of the GMR-
GAL4 driver. 
RESULTS
Lilli has a redundant function in photoreceptor cell
fate specification
Mutations in lilli were identified in two independent genetic
screens aimed at identifying novel components in the
Ras/MAPK pathway that regulates R7 photoreceptor
development. Dickson et al. (Dickson et al., 1996) recovered
multiple alleles of a complementation group called Su(Raf)2A
in a screen for mutations that dominantly suppress the
multiple-R7 phenotype resulting from constitutive activation of
the Raf kinase. Neufeld et al. (Neufeld et al., 1998) recovered
alleles of a complementation group called SS2-1 in a screen for
mutations that suppress the rough eye phenotype caused by
overexpression of Sina. Both Su(Raf)2A and SS2-1 were
mapped to the same chromosomal location (23C1-2) and
F. Wittwer and others
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belong to a single complementation group, which we renamed
lilliputian (lilli) based on the small size of homozygous lilli
mutant cells (see below). lilli mutant embryos show terminal
and segmentation defects (Dickson et al., 1996) and lilli
mutations are allelic with l(2)00632, which was identified in a
screen for zygotic lethal mutations with maternal effect
phenotypes (Perrimon et al., 1996). 
In contrast to its absolute requirement during embryogenesis
we have shown that lilli is dispensable for the specification of
the endogenous R7 (Dickson et al., 1996). However, it
is essential for the formation of ectopic R7 cells induced
by the activation of either Sev, Ras, Raf or MAPK in
the cone cell precursors (Dickson et al., 1996 and Fig.
1A,B). Interestingly, while the ectopic R7 cells caused
by constitutive activation of Raf were suppressed by
removal of one copy of lilli, the multiple-R7 phenotype
caused by constitutive activation of Sev, Ras, or MAPK
was only suppressed by complete removal of Lilli
function. To test whether Lilli is required only for the
formation of ectopic R7 cells or whether it also
performs a partially redundant function in the
endogenous R7 cell, we generated clones of lilli mutant
cells in a background containing the hypomorphic
rafHM7allele. The rafHM7 mutation causes a reduction of
raf transcript levels (Melnick et al., 1993) and leads to
the loss of R7, as well as some R1-R6 cells, in a subset
of ommatidia (Dickson et al., 1992, and Fig. 1C).
Indeed, the number of both R7 and R1-R6 cells in
rafHM7 mutants was further reduced significantly within
the lilli mutant clones (Fig. 1D). This result suggests
that Lilli functions not only in the formation of ectopic
R7 cells but also plays a partially redundant role
downstream of Raf in the specification of the
endogenous photoreceptor cells. 
Mutations in lilli affect growth and cell size
Although clones homozygous for lilli alleles in the adult
eye were wild-type with respect to photoreceptor cell
differentiation and arrangement, we noted that in clones
of strong alleles (i.e. lilli4U5 and lilli15D1) the size of the
photoreceptor cells was reduced in comparison to the
heterozygous cells adjacent to the clone (Fig. 2A).
Analysis of mosaic ommatidia showed that this
phenotype is cell autonomous. A reduction of cell size
in mutant tissue is typical for components of the
PI3K/PKB and Ras/MAPK pathways (Oldham et al.,
2000a; Weinkove and Leevers, 2000).
In addition to reducing cell size, loss of Lilli function
may also decrease cell number. Clones mutant for chico,
which display similar cell size defects as lilli, grow
more slowly and cannot compete with faster growing
wild-type cells (Boehni et al., 1999). In contrast, two
experiments indicate that growth of lilli mutant tissue is
not impaired during early larval development: first,
when we generated sister clones, one homozygous for
lilli, the other homozygous for chico, we found that lilli
mutant cells competed successfully with heterozygous
tissue while chico mutant cells were outcompeted (Fig.
2B). Second, the size of lilli clones was similar to that
of their wild-type sister clones in the wing imaginal disc
and the eye imaginal disc anterior to the furrow.
Posterior of the furrow however, lilli mutant clones where
significantly smaller than their wild-type sister clones (Fig.
2C,D). Cells posterior to the morphogenetic furrow undergo a
final round of cell division and are then integrated into the
ommatidial clusters (Freeman, 1997). The reduced clone size
could thus be the result of a failure of some lilli mutant cells
to undergo this last division or to a slight increase in apoptosis
in lilli clones posterior to the morphogenetic furrow. Using
TUNEL staining to detect cells undergoing apoptosis, and anti-
Fig. 1. Lilli is required in the R7 cell and acts downstream or in parallel of
rl/MAPK. (A) Histological sections through the sE-rlDN mutant eyes
containing ectopic R7 cells. sE-rlDN is a transgene encoding an activated
version of the MAPK expressed under control of the sev enhancer (Brunner
et al., 1994). (B) The formation of multiple R7 cells is suppressed in a lilli3E8
clone (marked by the absence of red pigment, clone border indicated by a red
line) in a sE-rlDN mutant background. One ommatidium containing
additional R7 cells and one ommatidium with a single R7 cell is indicated by
an arrowhead and arrow, respectively. On average, ommatidia outside the
lilli3E8 clone have 2.7 R7 cells (n=192) while ommatidia within a clone have
only 1.1 R7 cells (n=135). The difference in the number of R7 cells per
ommatidium was significant for all 4 eyes analyzed (t-test: P<0.005. For
each eye examined at least 24 ommatidia inside the clone where compared
with at least 27 ommatidia outside the clone). (C) A histological section
through an eye of a rafHM7/Y fly is shown. The rafHM7 mutation results in a
reduction in the number of photoreceptors per ommatidium. (D) In a
homozygous lilli3E8 clone (marked by the absence of red pigment) in a
rafHM7/Y background the number of photoreceptor cells is further reduced.
Outside the lilli3E8 clone, 26% of the ommatidia contain a normal
complement of photoreceptors. This number is reduced to 9% inside the
clone. This reduction is significant (t-test: P<0.01; percentages of complete
ommatidia in clones of 7 eyes were compared with percentages of complete
ommatidia in areas outside the clones in the same 7 eyes. The analyzed areas
contained between 17 and 48 ommatidia each). Genotypes: (A) y w; 2xsE-
rlSem(DN)/+; (B) y w hs-Flp/y w; lilli3E8 FRT40/P(w+) FRT40; 2xsE-
rlSem(DN)/+; (C) y w rafHM7/Y; (D) y w rafHM7 hs-Flp/Y; lilli3E8 FRT40/
P(w+) FRT40;
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phosphohistone H3 staining to detect mitotic cells, we were
unable to observe a significant difference between mutant and
control clones. The relatively small difference in clone size
may make it difficult to observe significant differences in cell
death or mitosis with methods that detect cells undergoing cell
death or cell division, respectively only at the time of the
experiment. Therefore, at present we do not know whether the
reduction in clone size posterior to the morphogenetic furrow
is due to an increase in apoptosis or an inhibition of the cell
cycle or a combination of both.
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Fig. 2. Lilli function is also required for cell and organ size but not for cell proliferation. (A) Tangential section through an eye containing a
lilli4U5 clone (marked by the absence of red pigment). Within the clone, all photoreceptor cells are reduced in size compared to the neighboring
wild-type and heterozygous photoreceptor cells. At the border of the clone, mosaic ommatidia composed of phenotypically wild-type
photoreceptors (marked by the faint yellowish pigment at the base of their rhabdomeres) and small mutant photoreceptor cells are visible,
indicating that lilli controls cell size autonomously. Some additional small lilli4U5 clones consisting of only few cells are visible dispersed in the
area of wild-type cells. (B) Cell competition assay. lilliP1 homozygous mutant cells are marked by the dark red pigment because they contain
two copies of the w+ marker. Cells heterozygous for lilliP1 and chico1 are orange (w+/w). Cells homozygous for chico1 are marked by the
absence of pigment (w/w) and are not visible in the adult eye because they have been out-competed by the faster growing heterozygous and
homozygous lilli cells. (C) Lilli is not required for cell proliferation but lilli clones posterior to the morphogenetic furrow are reduced in size
when compared to their sister clones. Confocal image of lilli4U5 mitotic clones that were generated by heat shock 48-72 hours after egg
deposition and analyzed in late third instar larvae. Clones of lilli4U5 cells are marked by the absence of anti-b -gal staining (not green). Their
corresponding sister clones are marked by the more intense green staining (two copies of lacZ). Nuclei are stained by TO-PRO (red). For two
clone/sister clone pairs the border is indicated. The gray bar at the top of the picture indicates the position of the morphogenetic furrow.
Anterior is to the left and dorsal is up in A-C. (D) Analysis of growth properties of lilli4U5 clones in comparison with their wild-type sister
clones in imaginal discs. The areas of clone/sister clone pairs in the pouch region of the wing imaginal disc, and in the eye imaginal disc either
anterior or posterior to the morphogenetic furrow are shown. Graphs show the sizes (clone areas in pixels) of individual pairs of lilli4U5 clones
(black bars) and +/+ sister clones (white bars). In addition, the area of the lilli4U5 clone relative to its sister clone was calculated for each pair.
The means of these values are (as a percentage of sister clone ± standard deviation): for wing pouch 102±19%, for the eye anterior to the
morphogenetic furrow: 83±33%, for the eye posterior to the morphogenetic furrow: 56±21%. Similar results were obtained for the lilli15D1
allele (data not shown).The ratio for clones in the eye posterior to the furrow was significantly smaller than the ratio for clones anterior to the
furrow (t-test: P<0.025; 9 ratios of clones anterior of the morphogenetic furrow were compared with 9 ratios of clones posterior to the furrow).
(E) Selective removal of Lilli function from the eye imaginal discs using the ey-Flp system (Newsome et al., 2000) results in heads that are
reduced in size (left fly) when compared to wild-type flies (right). Genotypes: (A) y w hs-Flp/y w; lilli4U5 FRT40/P(w+) FRT40; (B) y w ey-
Flp/Y; lilliP1 FRT40/chico1FRT40; (C) y w hs-Flp/y w; lilli4U5FRT40 /P(arm-lacZ w+) FRT40. (E, left side) y w ey-Flp/y w; lilli4U5
FRT40/P(w+) l(2)2L-3.1 FRT40; (E, right side) y w ey-Flp/y w; lilli4U5 FRT40/CyO.
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Consistent with the reduced clone size in the eye disc
posterior to the morphogenetic furrow we found that the
selective removal of Lilli function in eye and head precursor
cells by the ey-Flp system resulted in flies with reduced eye
and head size (Fig. 2E). The reduction in eye size was caused
by a reduction in both the number and size of ommatidia (24%
and 18%, respectively, for lilli4U5; Fig. 3I,K). The degree of
head size reduction allowed us to define a class of strong alleles
(e.g. lilli4U5, lilli15D1) and a class of weak alleles (e.g. lilli3E8,
lilliP1, lilliP4). The small head phenotype of lilli mutant tissue
is similar to that observed with components of the PI3K/PKB
pathway (Boehni et al., 1999; Montagne et al., 1999). 
Lilli partially suppresses the overgrowth phenotype
caused by the loss of PTEN function
Since loss of Lilli function affects cell size and head size, we
tested for genetic interactions between lilli and components
of the PI3K/PKB pathway. PTEN acts as a negative regulator
in the PI3K/PKB pathway by dephosphorylating the
second messenger phosphatidylinositol 3,4,5-trisphosphate
(PtdIns(3,4,5)P3; PIP3, for reviews see Rameh and Cantley,
1999; Di Cristofano and Pandolfi, 2000). Tissues mutant for
PTEN show hyperplastic and hypertrophic growth: PTEN
mutant cells are larger and proliferate at a higher rate than wild-
type cells (Goberdhan et al., 1999; Huang et al., 1999; Gao et
al., 2000). 
Removal of PTEN function from the eye imaginal disc tissue
using the ey-Flp system (Newsome et al., 2000) resulted in an
increase in eye and head size (Fig. 3A; Oldham et al., 2000b).
The increase in eye size was due to an increase in cell number
and cell size as indicated by the increase in number and size
of ommatidia (Fig. 3I,K). To test whether the PTEN large-head
phenotype was modified by the removal of Lilli function, we
generated PTEN, lilli double mutant eyes. Indeed, eyes double
mutant for PTEN and lilli were considerably smaller than
PTEN mutant eyes due to a reduction in cell number and cell
Fig. 3. lilli cooperates with
PI3K/PKB signaling.
(A-H) Scanning electron
micrographs of eyes in which
the function of PTEN or Lilli or
both has been removed from
most of the cells by the ey-Flp
system. Images in the same row
(i.e. A-D or E-H) were taken at
the same magnification. Scale
bars 100 m m (A-D) and 20 m m
(E-H). For A-D and L, anterior
is to the left and dorsal is up.
(A,E) Removal of PTEN leads to
increased size of the head
capsule and the eyes due to
hyperplastic growth. In addition,
the ommatidia are enlarged and
additional bristles are formed.
(B,F) Heads double mutant for
both PTEN and lilli are smaller
than those of PTEN single
mutants or wild type.
Interommatidial bristles are lost
in lilli, PTEN double mutant
heads. (C,G) lilli mutant heads
are smaller than wild-type heads
and have ommatidia of reduced
size. (D,H) Control flies in
which the ey-Flp system is used
in combination with an FRT40
chromosome alone (i.e. without
a mutation). The size of the head
is nearly wild type. (I) Number
of ommatidia in eyes of the
same genotype as shown in A-H.
Scanning electron micrographs of female flies of the indicated genotypes were taken and used to count ommatidia. The standard deviation is
indicated by the error bar. The differences between the mean values is significant (t-test: P<0.025, n=4 eyes for all genotypes). (K) Size of
ommatidia in eyes of the same genotype as shown in A-H. Scanning electron micrographs of female flies of the genotypes indicated were used
to determine the average area covered by an ommatidium, based on measurements of 7 neighboring ommatidia. The mean values are
significantly different except for the difference between ‘PTEN+lilli’ and ‘control’ (t-test: P<0.025, n=4 eyes for each genotype). (L) hs-Flp-
induced clone in the eye lacking both Lilli and PTEN function. The clone is marked by the absence of red (w+) pigment. One mutant
photoreceptor (no red pigment in rhabdomere) and a heterozygous photoreceptor (pigment present in rhabdomere) are marked by a black or a
white arrow, respectively. Genotypes: (A,E: ‘PTEN’): y w ey-Flp/y w; PTEN117.35 FRT40/P(w+) l(2)2L-3.1 FRT40; (B,F: ‘PTEN+lilli’) y w ey-
Flp/y w; lilli4U5 PTEN117.35 FRT40/ P(w+) l(2)2L-3.1 FRT40; (B,F: ‘lilli’) y w ey-Flp; lilli4U5 FRT40/P(w+) l(2)2L-3.1 FRT40; (D,H: ‘control’)
y w ey-Flp/y w; FRT40/P(w+) l(2)2L-3.1 FRT40; (L) y w, hs-Flp/y w; lilli4U5 PTEN117.35 FRT40/P(w+) FRT40.
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size (Fig. 3B,C,I,K). Loss of Lilli function, however, did not
completely suppress the PTEN phenotype. Although these
results suggest that Lilli and PTEN cooperate in the control of
cell and organ growth, the absence of a clear-cut epistasis
between the two mutants indicates that Lilli does not act
downstream of PTEN in a simple linear pathway but it rather
acts in a parallel pathway required for growth.
Molecular characterization of the lilli gene 
To identify the lilli gene, DNA flanking the lilli P-element
insertions (see Materials and Methods) was cloned and used to
initiate a genomic walk of the 23C1-2 region. A search for
cDNA clones in this region revealed several ESTs that
consisted of exons located near the insertion site of the P
elements. Sequencing of all available cDNAs defined a
transcription unit spanning a region of 67 kb and consisting of
12 exons (Fig. 4A). Since one P element is located in the first
intron and two other P elements are inserted in the second 54
kb intron, this transcription unit was a good candidate for the
lilli gene. Two further findings demonstrate that this candidate
gene is indeed responsible for Lilli function. First, missense or
nonsense mutations were identified in the predicted lilli
transcription unit in 8 out of 11 EMS-induced lilli alleles
examined (Fig. 4B, and see below). Second, low level
ubiquitous expression of a minigene rescue construct (UAS-lilli
in Fig. 4A) using a heat-shock-GAL4 driver in the absence of
heat shock rescued lilli homozygous mutant flies to adulthood.
The rescued flies appeared normal – except that the size of the
wing and the head was slightly reduced in comparison to wild-
type flies (data not shown). Furthermore, the dominant
suppression of the sE-RaftorY9-induced rough eye phenotype by
removal of one copy of lilli was reverted by expressing the
UAS-lilli minigene under the control of the sevE-sevP-GAL4
driver (data not shown). These results establish the identity of
the lilli gene. 
lilli encodes a novel nuclear protein related to the
mammalian AF4/FMR2 family of transcription factors 
The predicted lilli open reading frame encodes a protein of
1673 amino acids which has a C-terminal domain (amino acids
1418-1668, C-terminal homology domain, CHD, defined by
Nilson et al., 1997) homologous to members of the AF4/FMR2
family of mammalian proteins (Fig. 4B,F). In this region, Lilli
is 31-37% identical to the corresponding sequences of human
AF4, FMR2, AF5q13 and LAF4. Interestingly, the position of
the intron/exon boundaries within the region encoding the
CHD domain are conserved between lilli and the AF4 family
members suggesting that those exons have a common
evolutionary origin.
Searching the Drosophila genome database did not reveal
any sequences in addition to lilli that share homologies with
AF4/FMR2 family members. Thus lilli appears to be the only
member of this family in Drosophila. FMR2, AF4 and LAF4
are nuclear proteins and these have properties of transcription
factors. They possess a putative transactivation domain and
have the ability to bind DNA in vitro (Ma and Staudt, 1996;
Gu et al., 1996; Nilson et al., 1997; Gecz et al., 1997; Miller
et al., 2000). Like other family members, Lilli is rich in proline
and serine residues (9.0% and 12.7% of all amino acids,
respectively). For human AF4 and LAF4, the serine-rich region
has been shown to be situated in a part of the protein that has
transactivation potential (Ma and Staudt, 1996). Serines are
concentrated in Lilli at the same relative position as in
AF4/FMR2 family members (Ser domain, amino acid 860-965
of Lilli; Fig. 4B). However, domains within the AF4/FMR2
family members that are located N-terminal of the serine-rich
region (i.e. NHD domain and ALF domain, defined by Nilson
et al., 1997) are not present in Lilli.
In addition to the serine-rich region, two other features of
Lilli indicate a possible function in activating transcription:
first, four glutamine-rich stretches in the N-terminal region of
Lilli (Q1-Q4: amino acids 3-14, 32-48, 172-180 and 500-521)
Fig. 4. Molecular organization of the lilli locus and characterization
of mutant alleles. (A) Genomic structure of the lilli locus at 23C1-2.
The position of the centromere is to the right. Transcription units of
the b -subunit of the geranylgeranyl transferase (b -ggt), the NTPase,
and the RNA-binding protein 9 (rbp9) are indicated. For the lilli
transcript individual exons are shown. White boxes represent non-
coding sequences and black boxes the lilli coding region. The
approximate locations of P-element insertions in lilli (P1:
lilliP1=k05431, P2: lilliP2=k07920, P4: lilliP4=k16124) are indicated
by inverted triangles. Below, the lilli rescue construct is shown (see
text for details). (B) Schematic representation of the Lilli protein
indicating the predicted domains and sequence similarities to other
proteins (for amino acid positions see text). Lilli shares the serine-
rich (Ser) and the C-terminal homology domain (CHD) with proteins
of the AF4/FMR2 family but does not contain the NHD and ALF
domain. Q1-Q4: glutamine-rich stretches. Homology with POU:
region homologous to part of the transactivation domain of POU
class III transcription factor from chick. AT-hook: AT-hook motif.
NLS1 and NLS2: putative bipartite nuclear localization signals
predicted by the pfscan program (Swiss Institute for Experimental
Cancer Research, Epalinges, Switzerland). Locations of the mutant
lesions are indicated above the protein structure. Molecularly, the
mutations consist of the following changes (in brackets: first amino
acid affected by the mutation): lilli3E8: CAG (Q1192) fi TAG (stop);
lilli4P5: CGA (R803) fi TGA (stop); lilli4U5: 20 bp deletion starting
within the codon for T758 which results in the replacement of the
original amino acid sequence with a shorter sequence with shifted
reading frame; lilli5X5: CAG (Q1100) fi TAG (stop); lilli16F1: TAC
(Y1459) fi TTC (F1459) and GAG (E1461) fi GTG (V1461); lilli16Q1:
101 bp deletion, starting within the codon for L1534 which results in
the replacement of the original amino acid sequence with a shorter
sequence with shifted reading frame; lilli17G1: CGA (R1632) fi TGA
(stop); lilli22E1: CAA (Q500) fi TAA (stop). (C) A short amino acid
stretch in Lilli is homologous to part of the POU class III
transcription factor from chick. The black boxes indicate amino acid
identity while the gray boxes indicate amino acid similarity. Dots
indicate gaps in the sequence that were introduced to optimize the
alignment. (D) Alignment of the AT-hook of Lilli with that of human
HMG-I(Y) (Homo sapiens, amino acid 7-34; GenBank accession
number L46353) and rat HMG-I(Y) (Rattus norvegicus, amino acid
7-34; GenBank accession number U89695). Gaps and identical or
conserved positions are indicated as in C. (E) The HA-tagged version
of Lilli (Lilli-HA) is localized in the nucleus when overexpressed in
salivary glands. A confocal image of salivary glands stained with
anti-HA is shown. Lilli-HA expression was induced by heat shock in
larvae of the following genotype: y w; UAS-lilli-HA/+, hs-GAL4/+.
(F) Clustal W alignment of the CHD of Lilli and human AF5q31,
FMR2, AF4 and LAF4. Black boxes indicates amino acid identity,
gray boxes amino acid similarity in at least four of the five proteins.
Amino acids bordering splice sites are underlined for Lilli, AF4 and
FMR2. Note that most splice sites are conserved (arrows). The
conserved Tyr1459 that is replaced by alanine in allele lilli16F1 is
marked by an asterix. Gaps are indicated as in C.
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and, second, a domain (amino acid 245-300) with homology
to part of a putative transactivation domain from the POU class
III transcription factor (Fig. 4B,C; Levavasseur et al., 1998).
Lilli has two putative bipartite nuclear localization signals
(amino acid 889-906 and amino acid 1286-1303, respectively,
Fig. 4B). In addition, Lilli has a sequence (amino acid 836-
859; Fig. 4B,D) which matches the consensus sequence for the
HMG-I(Y) DNA binding motif, termed the AT-hook (Reeves
and Nissen, 1990). This DNA binding domain is not found in
other members of the AF4/FMR2 family. The AT-hook motif
binds to the minor groove of the DNA double helix at A/T-rich
sequences (Reeves and Nissen, 1990). 
Analysis of the EMS-induced mutations provided further
insight into putative functional domains of the Lilli protein
(Fig. 4B and figure legend). lilli4U5 contains a short deletion
resulting in a frameshift and is probably a functional null allele,
since the encoded protein lacks most of the predicted domains
including the AT-hook, the serine-rich domain, and the nuclear
localization signals. The lilli3E8 mutant protein is predicted
to have a C-terminal truncation but since it still retains the
putative DNA-binding and Ser domain it is likely to have
residual activity. Interestingly, although lilli3E8 was able to
suppress the RaftorY9 induced rough eye to the same extent as
the other EMS alleles or deficiencies for the locus, it showed
a less severe reduction in head size in ey-FLP mosaics than
lilli4U5 and lilli15D1 (data not shown). This suggests that the
very C-terminal domain of Lilli is essential for its function as
a transducer of the Raf signal but is less critical with regard to
its growth promoting role. In the protein encoded by lilli16F1,
Tyr1459 is replaced by alanine. Intriguingly, Tyr1459 is
conserved throughout the AF4/FMR2 family (Fig. 4F; the
phenotype of lilli16F1 in ey-Flp mosaics was weak and similar
to the Lilli3E8 phenotype).
Lilli protein is localized in the nucleus
lilli expression in the embryo was analyzed by in situ
hybridization. We found high levels of lilli mRNA in the
unfertilized egg, which is consistent with the maternal
requirement for Lilli function (Dickson et al., 1996; Perrimon
et al., 1996). In the early embryo and until gastrulation, lilli is
expressed uniformly. During later stages of embryogenesis, we
found a slightly elevated expression in the nervous system
(data not shown). In order to determine the subcellular
localization of Lilli, we generated an HA-tagged minigene
construct (UAS-lilli-HA, see Material and Methods). UAS-lilli-
HA rescued lilli lethality suggesting that this construct encodes
a functional Lilli protein (data not shown). Staining salivary
glands of larvae in which expression of the HA-tagged Lilli
(Lilli-HA) was induced by heat shock, revealed that Lilli-HA
is mainly localized in the nucleus (Fig. 4E). Nuclear
localization of Lilli-HA was also observed in the eye imaginal
disc (data not shown). Therefore, we believe that, like its
mammalian homologs, Lilli also normally functions in the
nucleus (Nilson et al., 1997; Miller et al., 2000).
DISCUSSION 
FMR2 and AF4 are the founding members of a family of
putative transcriptional activators in humans (Domer et al.,
1993; Nakamura et al., 1993; Chakrabarti et al., 1996; Gecz et
al., 1996; Gu et al., 1996). Little is known about their normal
cellular function, although mutations in the corresponding
genes are associated with human diseases such as mental
retardation and acute lymphoblastic leukemia. Here we
describe the characterization of the first invertebrate member
of this family. Lilli cooperates with the Ras/MAPK and the
PI3K/AKT pathway in the control of cell growth and cell
differentiation.
Lilli has a partially redundant function downstream
of Ras/MAPK signaling in cell fate specification
Loss-of-function mutations in lilli where identified as
dominant suppressors of the specification of supernumerary R7
photoreceptor cells in response to constitutive activation of Raf
in the developing eye (Dickson et al., 1996). However, without
constitutive activity of the Ras/MAPK pathway, the normal
number of photoreceptor cells is specified in each ommatidium
in the complete absence of Lilli function. Given the fact that
lilli encodes a putative transcription factor, a possible
explanation for why lilli mutants specifically suppress the
differentiation of extra R7 photoreceptor cells is that lilli may
be required for the expression of the sE-RaftorY99 transgene.
Indeed, we and others have noted that lilli mutations affect
transcript levels of transgenes containing a hsp70 basal
promoter (data not shown and Tang et al., 2001). Although the
effect of lilli on hsp70 transcription may explain some of the
genetic interactions (Greaves et al., 1999; Rebay et al., 2000),
it is not sufficient to explain the specific interaction with the
Raf/MAPK pathway for the following reasons. (1) In the
original screen, we used two different RaftorY9 transgenes. One
contained the sev enhancer fused to the hsp70 promoter (sE),
the other the sev enhancer fused to the sev promoter (sEsP;
Dickson et al., 1996). lilli mutations suppressed both. (2) lilli
mutations failed to suppress the rough eye phenotype caused
by the ectopic expression of rough under the control of the sev
enhancer and heat shock promoter. (3) Heterozygosity for lilli
does not suppress the multiple R7 phenotype of SevS11, a
transgene encoding a truncated version of the Sev receptor also
expressed under the control of the sev enhancer and the hsp70
promoter (sE; Basler et al., 1991). The formation of multiple
R7 cells caused by sE-SevS11 or sEsP-RasV12 (Fortini et al.,
1992) is only suppressed in homozygous lilli clones (Dickson
et al 1996). If lilli controlled expression of the sev enhancer,
we would expect a dominant suppression of all sev enhancer
driven transgenes. (4) Finally, as we show here, complete
loss of Lilli function in clones decreased the number of
photoreceptor cells recruited in the background of a
hypomorphic mutation of raf, rafHM7. Therefore, we conclude
that Lilli has a specific function in regulating the efficiency
of signal transduction downstream of Raf. As a putative
transcription factor, Lilli may regulate the expression levels of
one or multiple components of the Ras/MAPK signaling
pathway that become rate-limiting when Ras/MAPK signaling
is too high, in cells where it is normally low (as in the case of
ectopic activation of Raf in the eye), or when signaling is
reduced. 
Lilli function in growth control
Growth is controlled by many different signals and during
development it is tightly linked to pattern formation (Day and
Lawrence, 2000). In Drosophila, the insulin receptor controls
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growth via the PI3K/PKB pathway without affecting pattern
formation (reviewed by Oldham et al., 2000b; Weinkove and
Leevers, 2000). The EGF receptor also controls growth most
likely via the Ras/MAPK pathway (Diaz-Benjumea and Hafen,
1994; Prober and Edgar, 2000). Little is known about the
nuclear factors that integrate the signals from these two
pathways. Could the nuclear factor Lilli be a point of
convergence of these two pathways for growth control?
Although the cell size phenotype observed in lilli mutants is
similar to that of mutants in either of the two pathways,
mutations in lilli also display some unexpected phenotypes that
are difficult to reconcile with Lilli functioning exclusively as a
target of the two pathways. (1) lilli mutant cells do not have a
growth disadvantage during early imaginal disc development.
(2) The partial suppression of the overgrowth phenotype of
PTEN mutants by lilli mutants suggests a complex epistatic
relationship between lilli and the PI3K/PKB pathway. (3) Both
Lilli overexpression and lilli loss-of-function mutations reduce
cell size (Fig. 2A, and data not shown). This is in contrast to
components of the PI3K/PKB and Ras/MAPK signaling
pathways. Overexpression of PI3K or PKB increases cell size,
whereas loss-of-function mutations decrease cell size (Leevers
et al., 1996; Verdu et al., 1999; Weinkove et al., 1999).
Similarly, loss- and gain-of-function mutations of Ras have
opposite effects on cell size (Prober and Edgar, 2000). Lilli
may activate the transcription of genes involved in cell growth
and differentiation. 
Lilli and AF4/FMR2 phenotypes
How does the function of Lilli in Drosophila correlate with the
phenotypes observed in disease conditions associated with
mutations in the human homologs AF4, AF5q31 and FMR2? In
the case of acute lymphoblastic leukemia two related genes,
AF4 and AF5q31, are involved in translocations to the MLL
gene (also known as ALL-1, htrx), which encodes a human
homolog of the Drosophila protein Trithorax (Domer et al.,
1993; Nakamura et al., 1993; Taki et al., 1999, and references
therein). We show that Lilli function is essential for increased
acitivity in the Ras/MAPK pathway. Activating mutations in
Ras are frequently found in lymphomas but normally absent in
leukemias associated with MLL rearrangements (Mahgoub et
al., 1998, and references therein). It is possible that expression
of the MLL/AF4 fusion gene circumvents the need for Ras
activation in transformation. Recently, the targeted inactivation
of the Af4 gene in mice has been reported (Isnard et al., 2000).
Af4 mutant mice display an altered development of lymphoid
cells and, on a mixed 129/Balb/c background, a subset show a
significant reduction in body weight at birth. The reduction in
weight may suggest that AF4 and Lilli control cellular growth
in mice and Drosophila, respectively. Thus, further analysis of
Lilli function may provide insights into the function of this class
of nuclear proteins both in vertebrate development and disease. 
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